Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06577025
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-27
Brief Title:
A Study of Different Sequences of Cilta-cel Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab Bortezomib Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma
Sponsor:
Organization:
None